AdoptFly™ Series
Adoption
Intelligence
A willing champion is where adoption starts, and never where it finishes. This briefing reads everything in between: the shifts in policy, payment, and evidence that decide whether a cleared technology ever becomes a standard of care.
#16Latest
September 1, 2026
Periurethral hygiene at catheter maintenance: an evidence review.
Evidence ReviewCAUTI PreventionCDC GuidelinesPeriurethral Hygiene
#15
July 21, 2026
The protocol to prevent central-line infections had been published since 1983.
Standard of Care InvestigationCLABSIEnforcement vs EvidenceImplementation Infrastructure
#14
August 25, 2026
One of the fastest medical revolutions in history happened before the evidence existed.
Standard of Care InvestigationAdoption MechanismsLaparoscopic SurgeryPatient Demand
#13
July 22, 2026
Your technology works. That was never the question.
Real-World EvidenceHospital OutcomesClinical AdoptionEvidence StrategyClinical Workflow
#12
June 15, 2026
"It's FDA-cleared" is no longer the end of the conversation. It's the start.
RAPID PathwayCMS / FDACoverage & PaymentNTAP RepealImplant EvidenceValue Analysis Committee
#11
June 8, 2026
Medicare reviewed 66 wound-care products for coverage. Just one met the new bar.
Wound CareMedicare / CMSCoverage PolicySkin SubstitutesEvidence Standards
#10
June 1, 2026
What CMS did to wound care, it is now doing to implants
CMS PolicyPrior AuthorizationImplantsWISeRClinical AdoptionMarket Intelligence
#09
May 25, 2026
125 active clinical systems, no published comparative effectiveness data
Wound CareHaemostatic AgentsValue Analysis CommitteeEvidence StandardsCMS PolicyMAC Deadline
#08
May 18, 2026
Implantable materials face the same VAC evidence requirements as wound care — with less attention
Implantable MaterialsOrthopaedicsBiosynthetic MatricesBundled PaymentsValue Analysis CommitteeMAC Deadline
#07
May 11, 2026
A new dermal regeneration template — and what its peer-reviewed data tells us about where wound care evidence is heading
Dermal RegenerationWound CarePeer-Reviewed EvidenceValue-Based CareMAC DeadlineVascularisation
#06
May 4, 2026
The site-of-care shift — wound care is moving back to hospitals as the market adjusts to the CMS payment reset
Site-of-Care ShiftCMS Payment ResetBio-Integrative ImplantsFDA CategoriesValue-Based CareWound Care
#05
April 27, 2026
The WISER gold card, alternative collagen sources, and the LCD landscape shaping which products survive
WISER ComplianceLCD PolicyAlternative CollagenAngiogenesisValue-Based CareWound Care
Next Step
The briefing covers the field. This is about your technology.
An honest read on where your technology stands today, what your evidence doesn't yet show, and the one move that matters next.